GSK Investigational Site

Abbotsford British Columbia, British Columbia V2S 3N5

0 studies enrolling now · 3 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease — Completed
• Open-Label Extension Study of GSK1605786A — Stopped early
• GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease — Stopped early